Once Weekly Selinexor, Bortezomib, and Dexamethasone (SVd) Versus Twice Weekly Bortezomib and Dexamethasone (Vd) in Relapsed or Refractory Multiple Myeloma: High-Risk Cytogenetic Risk Planned Subgroup Analyses from the Phase 3 Boston Study - Richard, S; Chari, A; Delimpasi, S; Simonova, M; Spicka, I; Pour, L; Kryachok, I; Dimopoulos, MA; Pylypenko, H; Auner, HW; Leleu, X; Doronin, VA; et al. (AMER SOC HEMATOLOGY, 2020)